Role of the First Extracellular Loop in the Functional Activation of CCR2

The physiological cellular responses to monocyte chemoattractant protein-1 (MCP-1), a potent chemotactic and activating factor for mononuclear leukocytes, are mediated by specific binding to CCR2. The aim of this investigation is to identify receptor microdomains that are involved in high affinity agonist binding and receptor activation. The results from our functional studies in which we utilized neutralizing antisera against CCR2 are consistent with a multidomain binding model, previously proposed by others. The first extracellular loop was of particular interest, because in addition to a ligand-binding domain it contained also information for receptor activation, crucial for transmembrane signaling. Replacement of the first extracellular loop of CCR2 with the corresponding region of CCR1 decreased the MCP-1 binding affinity about 10-fold and prevented transmembrane signaling. A more detailed analysis by site-directed mutagenesis revealed that this receptor segment contains two distinct microdomains. The amino acid residues Asn104 and Glu105 are essential for high affinity agonist binding but are not involved in receptor activation. In contrast, the charged amino acid residue His100 does not contribute to ligand binding but is vital for receptor activation and initiation of transmembrane signaling. We hypothesize that the interaction of agonist with this residue initiates the conformational switch that allows the formation of the functional CCR2-G protein complex.

[1]  Robert V Farese,et al.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.

[2]  K. Murao,et al.  Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines* , 1997, The Journal of Biological Chemistry.

[3]  Jennifer C. Lee,et al.  CXC Chemokines Bind to Unique Sets of Selectivity Determinants That Can Function Independently and Are Broadly Distributed on Multiple Domains of Human Interleukin-8 Receptor B , 1996, The Journal of Biological Chemistry.

[4]  R. Mark,et al.  Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. , 1992, The Journal of biological chemistry.

[5]  O. Quehenberger,et al.  Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[6]  C. Martínez-A,et al.  The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. , 1997, The Journal of clinical investigation.

[7]  Y. Tokuda,et al.  cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor. , 1994, Biochemical and biophysical research communications.

[8]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[9]  I. Charo,et al.  The Amino-terminal Domain of CCR2 Is Both Necessary and Sufficient for High Affinity Binding of Monocyte Chemoattractant Protein 1 , 1997, The Journal of Biological Chemistry.

[10]  S. Coughlin,et al.  Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[12]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[13]  R. Bravo,et al.  Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor , 1997, The Journal of experimental medicine.

[14]  E. Prossnitz,et al.  Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach. , 1997, Biochemical and biophysical research communications.

[15]  J. Gong,et al.  An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model , 1997, The Journal of experimental medicine.

[16]  P. Kuna,et al.  Monocyte chemotactic and activating factor is a potent histamine- releasing factor for human basophils , 1992, The Journal of experimental medicine.

[17]  E. Leonard,et al.  Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. , 1990, Journal of immunology.

[18]  J. Kuratsu,et al.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants , 1989, The Journal of experimental medicine.

[19]  O. Quehenberger,et al.  Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. , 1999, Journal of lipid research.

[20]  T. Schall,et al.  Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor , 1993, Cell.

[21]  S. J. Myers,et al.  Signal Transduction and Ligand Specificity of the Human Monocyte Chemoattractant Protein-1 Receptor in Transfected Embryonic Kidney Cells (*) , 1995, The Journal of Biological Chemistry.

[22]  Terri L. Gilbert,et al.  Multiple activation steps of the N-formyl peptide receptor. , 1999, Biochemistry.

[23]  B. Dewald,et al.  RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors (*) , 1996, The Journal of Biological Chemistry.

[24]  Thomas A. Kunkel,et al.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Lazareno Measurement of Agonist-Stimulated [ 35 S]GTPγS Binding to Cell Membranes , 1997 .

[26]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Prossnitz,et al.  Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. , 1993, The Journal of biological chemistry.

[28]  I. Charo,et al.  The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. , 1996, The Journal of biological chemistry.

[29]  R. Horuk,et al.  Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. , 1993, The Journal of biological chemistry.

[30]  ANTAGONISTS OF MONOCYTE CHEMOATTRACTANT PROTEIN 1 IDENTIFIED BY MODIFICATION OF FUNCTIONALLY CRITICAL NH2-TERMINAL RESIDUES , 1995 .

[31]  Huiping Jiang,et al.  Selective G Protein Coupling by C-C Chemokine Receptors (*) , 1996, The Journal of Biological Chemistry.

[32]  T. Springer,et al.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  I. Charo,et al.  Differential Regulation of G-protein-mediated Signaling by Chemokine Receptors* , 1996, The Journal of Biological Chemistry.

[34]  Michel Bouvier,et al.  Structural and functional aspects of G protein-coupled receptor oligomerization. , 1998 .

[35]  D. Largaespada,et al.  Lymphotactin: a cytokine that represents a new class of chemokine. , 1994, Science.

[36]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[37]  M. Kozak Structural features in eukaryotic mRNAs that modulate the initiation of translation. , 1991, The Journal of biological chemistry.

[38]  B. Rollins,et al.  Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Rollins,et al.  Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. , 1994, The Journal of biological chemistry.

[40]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.